Antiarrhythmic formulation
Grant
US12576073B2
Kind: B2
Mar 17, 2026
Assignee
InCarda Therapeutics, Inc.
Inventors
Michael Laird Hurrey, Luiz Belardinelli, Prashanti Madhavapeddi, Carlos Schuler
Abstract
Pharmaceutical compositions comprising an antiarrhythmic agent for treatment of a heart condition via inhalation. Methods of treating a heart condition include administering by inhalation an effective amount of at least one antiarrhythmic pharmaceutical agent to a patient in need thereof. Nebulized drug product and kits are also disclosed.
CPC Classifications
A61K 31/4458
Filing Date
2022-01-13
Application No.
17574901
Claims
21